TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | 1 | 0 | 5 | -7 | -12 | -2 |
| P | %wins | 100 | 100 | 100 | 100 | 0 | 0 | 67 | |||
| S | %ret | 1 | 1 | 2 | 1 | 0 | -2 | 3 | 0 | 4 | 1 |
| S | %wins | 50 | 50 | 100 | 50 | 50 | 50 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/19/23 14:39 | 5/17/23 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Doyle Katherine C. | MI | D | M.d | 256 | 32.86 | 0 | 8 | 296 | 10 | D | |||||||||||||||
5/19/22 13:54 | 5/17/22 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Doyle Katherine C. | MI | D | M.d | 255 | 38.57 | 0 | 7 | 6 | D | ||||||||||||||||
8/16/21 12:02 | 8/12/21 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Doyle Katherine C. | MI | D | M.d | 233 | 41.28 | 0 | 6 | 3 | D | ||||||||||||||||
3/13/15 17:29 | 10/31/13 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Doyle Katherine C. | IL | O | SVP | P.m | 6 | 37.52 | 33 | 0 | 0 | 43 | D | 41 | 22 | 11 | 5 | 4 | 0 | 0 | 1 | 2 | 1 | 0 | 5 | -7 | -12 |
3/13/15 17:29 | 2/3/14 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Doyle Katherine C. | IL | O | SVP | S.m | 0 | 37.43 | 33 | 0 | 0 | 43 | D | 41 | 22 | 11 | 5 | 4 | 0 | 0 | 1 | 2 | 1 | 0 | 5 | -7 | -12 |
3/4/14 17:04 | 3/3/14 | ABT | Abbott Laboratories | IL | Health | Drug | Pharmaceutical Preparations | Doyle Katherine C. | IL | O | SVP | S | -259 | 39.01 | 33 | -7 | -12 | 48 | D | 50 | 19 | 18 | 3 | 0 | 6 | 1 | 0 | -1 | -1 | -4 | 0 | 7 | 20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |